Table 2 Characteristics of the study population
Patient characteristics | % (n = 32,075) |
|---|---|
Global cardiovascular adherencea | |
 Full adherence | 43.2 (13,855) |
 Partial adherence | 43.4 (13,914) |
 Full non-adherence | 13.4 (4306) |
Age at baseline | |
 50–70 | 44.2 (14,186) |
 71–75 | 22.8 (7299) |
 76–80 | 15.4 (4945) |
 > 80 | 17.6 (5645) |
Type of BC surgery | |
 Tumorectomy | 76.0 (24,363) |
 Total mastectomy | 24.0 (7712) |
Adjuvant chemotherapy in the year before AET | |
 No | 74.0 (23,740) |
 Yes | 26.0 (8335) |
Number of prescribed cardiovascular drugs | |
 2 | 37.3 (11,966) |
 3 | 37.0 (11,854) |
 4 | 25.6 (8255) |
 5–6 |  |
Time since initiation of any CV treatment | 52.7 (16910) |
 < 5 years | 31.3 (10,038) |
 ≥ 5 years | 12.3 (3958) |
Number of comorbidities (besides BCÂ and CV risk) | 3.6 (1169) |
 0 |  |
 1 | 13.3 (4269) |
 ≥ 2 | 86.7 (27,806) |
Number of hospital stays in the year before AET | |
 0 | 80.1 (25,694) |
 1 | 14.4 (4611) |
 ≥ 2 | 5.5 (1770) |
FDEPb | |
 Q1 | 17.8 (5725) |
 Q2 | 18.4 (5894) |
 Q3 | 19.6 (6290) |
 Q4 | 21.2 (6801) |
 Q5 | 23.0 (7365) |
Financial aid for complementary health insurance | |
 No | 96.3 (30,877) |
 Yes | 3.7 (1198) |